Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advaxis names VP, clinical ops

This article was originally published in Scrip

Executive Summary

Advaxis, a clinical-stage biotechnology company developing cancer immunotherapies, has appointed Thomas W Hare vice-president of clinical operations. Mr Hare brings to Advaxis more than 28 years of experience in the biopharmaceutical and contract research organization industries overseeing the management of global commercial and clinical operations, data management, outsourcing and medical writing groups. Most recently, he was vice-president of drug development operations at Incyte. In his new role he will report to Advaxis' executive vice-president, chief medical officer, Dr David J Mauro, and will oversee clinical operations for the company's multiple Lm-LLO cancer immunotherapy clinical programs.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel